About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com . Overview The Production Planner is the owner and responsible for managing and scheduling production plans for sampling, testing, issuance, bulk manufacturing, and final product shipments at Iovance Cell Therapy Center (iCTC) located in Navy Yard, PA and third-party manufacturing contractors as required. The Production Planner is key communication link between Manufacturing, Materials, Quality, Logistics, Maintenance, MSAT, Commercial, Clinical, and other teams to address additions, changes, substit
Role overview
Job description
Territory: Keystone including Philadelphia and New Jersey. Natera is seeking an experienced Clinical Oncology Specialist (COS) to join our specialized Genitourinary (GU) Oncology sales team. This high-impact, tumor-specific role will focus on driving adoption and growth of Signatera™, Natera's personalized, tumor-informed molecular residual disease (MRD) test , across the GU Oncology landscape. Signatera is a circulating tumor DNA (ctDNA) assay designed to detect molecular residual disease and monitor disease recurrence. Across GU cancers, including bladder, renal cell carcinoma, and testicular cancers, Signatera provides highly specific molecular insights that can help clinicians assess recurrence risk, monitor disease status, and inform individualized patient management strategies. The Clinical Oncology Specialist will serve as a strategic field partner and key representative of Nate
…Role market pulse
How Clinical Oncology Specialist demand looks in United States
Live jobs
24
Posted 30d
9
30d movement
-40%
Remote share
0%
Salary listed
100%
Salary trend 1Y
Not enough history
What they are looking for
Skills & requirements
Qualification
Qualifications Bachelor's degree required; All qualified applicants are encouraged to apply, and will be considered without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, age, veteran status, disability or any other legally protected status; We also consider qualified applicants regardless of criminal histories, consistent with applicable laws
Department · Oncology Sales
Hiring company
Natera
Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care.
Related opportunities
Similar active roles
Relevant, currently active roles for this market.
🔔 Get job alerts
New Clinical Oncology Specialist, GU jobs in Philadelphia, Pennsylvania, United States, straight to your inbox.
No spam · Unsubscribe anytime